170 related articles for article (PubMed ID: 93586)
1. Enhancement of feline leukemia virus-induced leukemogenesis in cats exposed to methylnitrosourea.
Schaller JP; Mathes LE; Hoover EA; Olsen RG
Int J Cancer; 1979 Nov; 24(5):700-5. PubMed ID: 93586
[TBL] [Abstract][Full Text] [Related]
2. Feline leukemia virus infection: age-related variation in response of cats to experimental infection.
Hoover EA; Olsen RG; Hardy WD; Schaller JP; Mathes LE
J Natl Cancer Inst; 1976 Aug; 57(2):365-9. PubMed ID: 187771
[TBL] [Abstract][Full Text] [Related]
3. Feline oncornavirus-associated cell membrane antigen: a viral and not a cellularly coded transformation-specific antigen of cat lymphomas.
Vedbrat SS; Rasheed S; Lutz H; Gonda MA; Ruscetti S; Gardner MB; Prensky W
Virology; 1983 Jan; 124(2):445-61. PubMed ID: 6186079
[TBL] [Abstract][Full Text] [Related]
4. Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies.
Lutz H; Pedersen NC; Theilen GH
Am J Vet Res; 1983 Nov; 44(11):2054-9. PubMed ID: 6316819
[TBL] [Abstract][Full Text] [Related]
5. The feline oncornavirus-associated cell membrane antigen (FOCMA) is related to, but distinguishable from, FeLV-C gp70.
Snyder HW; Singhal MC; Zuckerman EE; Jones FR; Hardy WD
Virology; 1983 Dec; 131(2):315-27. PubMed ID: 6318434
[TBL] [Abstract][Full Text] [Related]
6. Relationship between feline leukemia virus antigen expression and viral infectivity in blood, bone marrow, and saliva of cats.
Hoover EA; Olsen RG; Mathes LE; Schaller JP
Cancer Res; 1977 Oct; 37(10):3707-10. PubMed ID: 198120
[TBL] [Abstract][Full Text] [Related]
7. Feline oncornavirus-associated cell membrane antigen. III. Antibody titers in cats from leukemia cluster households.
Essex M; Jakowski RM; Hardy WD; Cotter SM; Hess P; Sliski A
J Natl Cancer Inst; 1975 Mar; 54(3):637-41. PubMed ID: 164563
[TBL] [Abstract][Full Text] [Related]
8. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
[TBL] [Abstract][Full Text] [Related]
9. Horizontal transmission of feline leukemia virus under natural conditions in a feline leukemia cluster household.
Essex M; Cotter SM; Sliski AH; Hardy WD; Stephenson JR; Aaronson SA; Jarrett O
Int J Cancer; 1977 Jan; 19(1):90-6. PubMed ID: 188773
[TBL] [Abstract][Full Text] [Related]
10. Infection with feline leukemia virus associated with induction of humoral response to a normal cell protein.
Chen AP; Essex ME
Cancer Invest; 1984; 2(2):81-90. PubMed ID: 6329486
[TBL] [Abstract][Full Text] [Related]
11. Vaccination against feline leukaemia virus using a cell membrane antigen system.
Jarrett W; Jarrett O; Mackey L; Laird H; Hood C; Hay D
Int J Cancer; 1975 Jul; 16(1):134-41. PubMed ID: 170211
[TBL] [Abstract][Full Text] [Related]
12. Natural feline leukemia virus infection and the immune response of cats of different ages.
Grant CK; Essex M; Gardner MB; Hardy WD
Cancer Res; 1980 Mar; 40(3):823-9. PubMed ID: 6258787
[TBL] [Abstract][Full Text] [Related]
13. Feline oncornavirus-associated cell membrane antigen. VI. Cytotoxic antibody in cats exposed to feline leukemia virus.
Mathes LE; Yohn DS; Hoover EA; Essex M; Schaller JP; Olsen RG
J Natl Cancer Inst; 1976 Jun; 56(6):1197-200. PubMed ID: 186623
[TBL] [Abstract][Full Text] [Related]
14. Feline oncornavirus-associated cell membrane antigen. IV. Antibody titers in cats with naturally occurring leukemia, lymphoma, and other diseases.
Essex M; Cotter SM; Hardy WD; Hess P; Jarrett W; Jarrett O; Mackey L; Laird H; Perryman L; Olsen RG; Yohn DS
J Natl Cancer Inst; 1975 Aug; 55(2):463-7. PubMed ID: 169377
[TBL] [Abstract][Full Text] [Related]
15. Feline oncornavirus-associated cell-membrane antigen (FOCMA): distinction between FOCMA and the major virion glycoprotein.
Stephenson JR; Essex M; Hino S; Hardy WD; Aaronson SA
Proc Natl Acad Sci U S A; 1977 Mar; 74(3):1219-23. PubMed ID: 191832
[TBL] [Abstract][Full Text] [Related]
16. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
Rojko JL; Hoover EA; Finn BL; Olsen RG
J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
[TBL] [Abstract][Full Text] [Related]
17. Study of feline leukemia virus immunity.
Charreyre C; Pedersen NC
J Am Vet Med Assoc; 1991 Nov; 199(10):1316-24. PubMed ID: 1666074
[TBL] [Abstract][Full Text] [Related]
18. Increased susceptibility to feline leukemia virus infection in cats exposed to methylnitrosourea.
Schaller JP; Mathes LE; Hoover EA; Koestner A; Olsen RG
Cancer Res; 1978 Apr; 38(4):996-8. PubMed ID: 205356
[TBL] [Abstract][Full Text] [Related]
19. Natural immunity in cats to feline leukemia viral antigens.
Ruscetti SK; Parks WP
J Immunol; 1976 Nov; 117(5 Pt.2):2029-35. PubMed ID: 186536
[TBL] [Abstract][Full Text] [Related]
20. Association of feline leukemia virus with lymphosarcoma and other disorders in the cat.
Cotter SM; Hardy WD; Essex M
J Am Vet Med Assoc; 1975 Mar; 166(5):449-54. PubMed ID: 163223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
